Mutant porcine reproductive and respiratory syndrome virus

Details for Australian Patent Application No. 2005303510 (hide)

Owner Pfizer Products Inc.

Inventors Lee, Changhee; Yoo, Dongwan; Calvert, Jay Gregory

Agent Shelston IP

Pub. Number AU-B-2005303510

PCT Pub. Number WO2006/051396

Priority 60/626,767 11.11.04 US

Filing date 2 November 2005

Wipo publication date 18 May 2006

Acceptance publication date 3 February 2011

International Classifications

C12N 15/40 (2006.01) Mutation or genetic engineering - Proteins from RNA viruses, e.g. flaviviruses

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/051396 Priority application(s): WO2006/051396

3 February 2011 Application Accepted

  Published as AU-B-2005303510

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303520-Over dosage indicating medicated film strip

2005303507-Sea wave energy converter